These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22452951)

  • 1. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): immunohistochemical profile in comparison to normal hair follicles.
    Misago N; Toda S; Narisawa Y
    Am J Dermatopathol; 2012 Jun; 34(4):394-9. PubMed ID: 22452951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus of tricholemmal differentiation (tricholemmal carcinoma) within Bowen's disease/carcinoma.
    Misago N; Toda S; Nakao T
    J Dermatol; 2016 Apr; 43(4):439-42. PubMed ID: 26365015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folliculocentric squamous cell carcinoma with tricholemmal differentiation: a reappraisal of tricholemmal carcinoma.
    Misago N; Toda S; Narisawa Y
    Clin Exp Dermatol; 2012 Jul; 37(5):484-91. PubMed ID: 22712857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma with clear cells: how often is there evidence of tricholemmal differentiation?
    Dalton SR; LeBoit PE
    Am J Dermatopathol; 2008 Aug; 30(4):333-9. PubMed ID: 18645304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS; Teleman S; Ungureanu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal Seborrheic Keratosis Versus Pagetoid Bowen Disease: Histopathology and Role of Adjunctive Markers.
    Kalegowda IY; Böer-Auer A
    Am J Dermatopathol; 2017 Jun; 39(6):433-439. PubMed ID: 28475506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 and BerEP4 Are Helpful to Distinguish Basaloid Tricholemmoma From Basal Cell Carcinoma.
    Turnbull N; Ghumra W; Mudaliar V; Vella J; Sanders DSA; Taibjee S; Carr R
    Am J Dermatopathol; 2018 Aug; 40(8):561-566. PubMed ID: 29570129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin.
    Ishida M; Kushima R; Okabe H
    J Cutan Pathol; 2008 Oct; 35(10):926-30. PubMed ID: 18537863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34 expression in human hair follicles and tricholemmoma: a comprehensive study.
    Misago N; Toda S; Narisawa Y
    J Cutan Pathol; 2011 Aug; 38(8):609-15. PubMed ID: 21762201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen's Disease of the Hand.
    Dorfer S; Kancz S; Birner P; Strasser K; Kirnbauer R; Petzelbauer P; Radakovic S; Harpain L; Pehamberger H; Thalhammer F; Handisurya A
    Acta Derm Venereol; 2019 Apr; 99(4):462-463. PubMed ID: 30653652
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of Bowen's disease with topical maxacalcitol.
    Karashima T; Hashikawa K; Ono F; Eguchi H; Hamada T; Ishii N; Dainichi T; Yasumoto S; Tsuruta D; Hashimoto T
    Acta Derm Venereol; 2012 Nov; 92(6):660-1. PubMed ID: 22281814
    [No Abstract]   [Full Text] [Related]  

  • 13. Sebaceous carcinoma associated with Bowen's disease: a case report with emphasis on the pathogenesis of sebaceous carcinoma.
    Ishida M; Iwai M; Yoshida K; Kagotani A; Okabe H
    Int J Clin Exp Pathol; 2013; 6(12):3029-32. PubMed ID: 24294397
    [No Abstract]   [Full Text] [Related]  

  • 14. Tricholemmal carcinoma in continuity with trichoblastoma within nevus sebaceus.
    Misago N; Narisawa Y
    Am J Dermatopathol; 2002 Apr; 24(2):149-55. PubMed ID: 11979076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms.
    Lining X; Uchi H; Hayashida S; Tsuji G; Kido M; Nakahara T; Takeuchi S; Takahara M; Moroi Y; Furue M
    J Dermatol Sci; 2009 Nov; 56(2):135-6. PubMed ID: 19660915
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
    Ichikawa E; Watanabe S; Otsuka F
    Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-existence of extramammary Paget's disease and Bowen's disease of vulva.
    Goyal T; Varshney A; Solanki R
    Indian J Dermatol Venereol Leprol; 2014; 80(6):530-3. PubMed ID: 25382511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
    Fernandez-Flores A
    Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All Bowen's disease is squamous cell carcinoma in situ, but all squamous cell carcinoma in situ is not Bowen's disease.
    Martin AA; Hudgins EM; McMullan FH
    J Cutan Pathol; 2010 Nov; 37(11):1186-7. PubMed ID: 20579212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.